Amgen (AMGN) Acquisitions (2011 - 2022)
Amgen's quarterly Acquisitions came in at $3.8 billion in Q4 2022, up 331.35% year-on-year from $890.0 million in Q4 2021, and up 331.35% quarter-over-quarter from $890.0 million in Q4 2021.
Amgen has reported Acquisitions for 10 years, with the latest figure at $3.8 billion in Q4 2022.
- For the quarter ending Q4 2022, Acquisitions rose 331.35% year-over-year to $3.8 billion; the trailing twelve-month figure through Dec 2022 stood at $4.7 billion (up 425.14% YoY), and the FY2025 full-year result was $53.0 million, changed N/A from the prior year.
- Acquisitions for Q4 2022 stood at $3.8 billion, up from $890.0 million in the prior quarter.
- The five-year high for Acquisitions was $13.4 billion in Q4 2019, with the low at -$197.0 million in Q1 2018.
- Average Acquisitions over 4 years is $2.6 billion, with a median of $177.0 million recorded in 2019.
- Year-over-year, Acquisitions slumped 89.47% in 2018 and jumped 671900.0% in 2019.
- Tracing AMGN's Acquisitions over 4 years: stood at $2.0 million in 2018, then jumped by 671900.0% to $13.4 billion in 2019, then slumped by 93.38% to $890.0 million in 2021, then soared by 331.35% to $3.8 billion in 2022.
- The last three Acquisitions figures came in at $3.8 billion (Q4 2022), $890.0 million (Q4 2021), and $13.0 million (Q3 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | - |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | - |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 8.78 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 109.00 Mn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 65.00 Mn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 3.84 Bn |
| Dec 31, 2021 | 890.00 Mn |
| Sep 30, 2021 | 13.00 Mn |
| Dec 31, 2019 | 13.44 Bn |
| Sep 30, 2019 | 177.00 Mn |
| Dec 31, 2018 | 2.00 Mn |
| Mar 31, 2018 | -197.00 Mn |
| Dec 31, 2017 | 19.00 Mn |
| Dec 31, 2015 | 359.00 Mn |
| Dec 31, 2014 | 50.00 Mn |
| Jun 30, 2014 | 11.00 Mn |
| Mar 31, 2014 | 104.00 Mn |
| Dec 31, 2013 | 9.43 Bn |
| Dec 31, 2012 | 400.00 Mn |
| Sep 30, 2012 | 319.00 Mn |
| Jun 30, 2012 | 702.00 Mn |
| Mar 31, 2012 | 969.00 Mn |
| Jun 30, 2011 | 298.00 Mn |
| Mar 31, 2011 | 403.00 Mn |